ProShare Advisors
ACHV icon

ProShare Advisors’s Achieve Life Sciences ACHV Stock Holding History

ProShare Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7
Closed -$175K – 2446
2014
Q1 		$175K Buy
+7
New +$172K ﹤0.01% 2557

Other funds holding ACHV

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ProShare Advisors's ACHV Position: Q2 2014 in Review

ProShare Advisors sold out of Achieve Life Sciences (ACHV) in Q2 2014, closing a stake of 7 shares — an estimated $175K sold.

ProShare Advisors first reported a position in ACHV in Q1 2014 and held it in 1 quarter. The position peaked at $175K in Q1 2014. 63 funds tracked by Wall St. Rank hold ACHV as of Q2 2014.

  • ProShare Advisors reported no remaining Achieve Life Sciences position as of Q2 2014 after selling out during the quarter.
  • ProShare Advisors sold 7 Achieve Life Sciences shares in Q2 2014, an estimated $175K.
  • ProShare Advisors first reported a position in Achieve Life Sciences in Q1 2014 and held it in 1 quarter.
  • ProShare Advisors's Achieve Life Sciences position peaked at $175K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2014.

Based on ProShare Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.